Yanchun Ding Selected Research

dihydroethidine

1/2022

Neohesperidin Protects Angiotensin II-Induced Hypertension and Vascular Remodeling.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Yanchun Ding Research Topics

Disease

2	Inflammation (Inflammations) 01/2022 - 09/2020
2	Hypertension (High Blood Pressure) 01/2022 - 01/2021
2	Fibrosis (Cirrhosis) 01/2022 - 09/2020
2	Hypertrophy 01/2022 - 09/2020
2	Left Ventricular Hypertrophy (Ventricular Hypertrophy, Left) 07/2021 - 01/2021
1	Necrosis 01/2022
1	Vascular Remodeling 01/2022
1	Essential Hypertension 05/2021
1	Hyperaldosteronism (Conn Syndrome) 01/2021
1	Adenoma (Adenomas) 01/2021
1	Carcinogenesis 09/2020
1	Cardiomegaly (Heart Hypertrophy) 09/2020
1	Pulmonary Hypertension 10/2016
1	Hypoxia (Hypoxemia) 10/2016

Drug/Important Bio-Agent (IBA)

2	neohesperidinIBA 01/2022 - 09/2020
2	Angiotensin IIIBA 01/2022 - 09/2020
2	Irbesartan FDA LinkGeneric 07/2021 - 01/2021
1	AntioxidantsIBA 01/2022
1	Chemokine CCL2 (Monocyte Chemoattractant Protein 1)IBA 01/2022
1	dihydroethidineIBA 01/2022
1	Diltiazem (Cardizem)FDA LinkGeneric 07/2021
1	Perindopril FDA LinkGeneric 07/2021
1	Angiotensin Receptor AntagonistsIBA 05/2021
1	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 05/2021
1	Antihypertensive Agents (Antihypertensives)IBA 01/2021
1	ReninIBA 01/2021
1	Spironolactone (Aldactone)FDA LinkGeneric 01/2021
1	AldosteroneIBA 01/2021
1	Proteins (Proteins, Gene)FDA Link 09/2020
1	Messenger RNA (mRNA)IBA 09/2020
1	procyanidinIBA 10/2016
1	Cyclin D1IBA 10/2016
1	Cyclin D3IBA 10/2016

Therapy/Procedure

1	Therapeutics 05/2021